title: Splenectomy abrogates the induction of oral tolerance in experimental autoimmune uveoretinitis.
abstract: Oral administration of uveitogenic antigens inhibits the development of experimental autoimmune uveoretinitis (EAU) and the cellular immune response initiated by these antigens. The mechanism of oral tolerance is not completely clear, but accumulating data indicate that suppressor cells are actively involved in this process. The spleen is known to harbor suppressor cells and their precursors and the present study was aimed at testing the role of this organ in the induction of oral tolerance by S-antigen (S-AG). We report here that: (a) splenectomy abrogated the induction of oral tolerance; unlike in sham operated controls, feeding with S-Ag did not inhibit the development of EAU in splenectomized rats; (b) splenectomized rats responded with higher cellular immune responses than did sham operated controls, but feeding with S-Ag inhibited these responses in both groups of animals; (c) splenectomy also abrogated the adoptive transfer of tolerance: EAU induction was inhibited in sham operated recipients of splenocytes from S-Ag fed donors but not in the splenectomized recipients. The data thus indicate that the spleen plays an important role in the induction of oral tolerance, perhaps by acting as the site for induction and/or amplification of cells with suppressor activity.
authors.affiliation: Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, MD 20892.
authors.forename: E D
authors.initials: ED
authors.lastname: Suh
authors.forename: B P
authors.initials: BP
authors.lastname: Vistica
authors.forename: C C
authors.initials: CC
authors.lastname: Chan
authors.forename: J M
authors.initials: JM
authors.lastname: Raber
authors.forename: I
authors.initials: I
authors.lastname: Gery
authors.forename: R B
authors.initials: RB
authors.lastname: Nussenblatt
mesh_terms: D000818:Animals; D000941:Antigens / Q000276:immunology; D019393:Arrestin; D001327:Autoimmune Diseases / Q000276:immunology* / Q000517:prevention & control; D005136:Eye Proteins / Q000276:immunology; D007109:Immunity; D007074:Immunoglobulin G / Q000276:immunology; D007165:Immunosuppression Therapy; D016219:Immunotherapy, Adoptive; D008213:Lymphocyte Activation / Q000276:immunology; D008297:Male; D009061:Mouth Mucosa / Q000276:immunology*; D051381:Rats; D011917:Rats, Inbred Lew; D012173:Retinitis / Q000276:immunology* / Q000517:prevention & control; D013154:Spleen / Q000276:immunology; D013156:Splenectomy; D015866:Uveitis, Posterior / Q000276:immunology* / Q000517:prevention & control
chemical_list: D000941:Antigens; D019393:Arrestin; D005136:Eye Proteins; D007074:Immunoglobulin G